Skip to main content
Premium Trial:

Request an Annual Quote

Bjrn Ekstrm, Charles Jeuell, Anna Koostra, Thomas Heydler

Premium

Björn Ekström has become CEO of Olink Bioscience, a Swedish startup focusing on protein analysis technology. Previously, Ekström was head of R&D at Pyrosequencing. He also held several positions within R&D at Amersham Biosciences and Pharmacia Biotech.


Midwest BioResearch, which provides outsourced drug disposition and toxicology services, has appointed Charles Jeuell as its vice president of analytical operations and Anna Koostra as a senior-level research scientist in the company’s protein bioanalysis group, the company said last week.


Thomas Heydler has been appointed the new CEO of Definiens, a Munich, Germany-based company that specializes in providing high-content image analysis software.

Prior to joining Definiens, Heydler was president and CEO at InterPro Business Solutions and Barcelona Design. Before that, he was vice president and executive officer at Documentum, a pharmaceutical and life sciences software company.

 

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.